Synthesis and evaluation of phenylisoserine derivatives for the SARS-CoV 3CL protease inhibitor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Synthesis and evaluation of phenylisoserine derivatives for the SARS-CoV 3CL protease inhibitor

Published:2017-06 Issue:12 Volume:27 Page:2746-2751
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Konno Hiroyuki,Onuma Takumi,Nitanai Ikumi,Wakabayashi Masaki,Yano Shigekazu,Teruya Kenta,Akaji Kenichi

Funder

Japan Science and Technology Agency

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference22 articles.

1. A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong

2. Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome

3. A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

4. Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: Structure–activity relationship study

5. Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: A comprehensive review;European Journal of Medicinal Chemistry;2023-11

2. An overview on medicinal plants used for combating coronavirus: Current potentials and challenges;Journal of Agriculture and Food Research;2023-09

3. An Updated and Focused Review on Heterocyclic Inhibitors for SARSCoV and SARS-CoV-2 3CLpro;Mini-Reviews in Medicinal Chemistry;2023-03

4. SARS-CoV-2: Potential Drug Targets and Its Virtual Screening;Modeling, Control and Drug Development for COVID-19 Outbreak Prevention;2021-11-02

5. Repurposing of available antiviral drugs against SARS-CoV-2 by targeting crucial replication machinery proteins;Egyptian Pharmaceutical Journal;2021-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3